Jan-05-21 Downgrade
BofA Securities
Buy → Neutral
$127
Jan-24-20 Upgrade
Goldman
Neutral → Buy
$72 → $97
Nov-07-19 Downgrade
Raymond James
Outperform → Mkt Perform
Oct-25-19 Downgrade
Wolfe Research
Outperform → Peer Perform
Sep-11-19 Downgrade
William Blair
Outperform → Mkt Perform
Jul-26-19 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $65
Jan-08-19 Upgrade
UBS
Sell → Neutral
Jan-03-19 Initiated
Deutsche Bank
Buy
$60
Dec-14-18 Initiated
Barclays
Overweight
Nov-28-18 Upgrade
Raymond James
Mkt Perform → Outperform
Nov-16-18 Initiated
UBS
Sell
$64
Nov-08-18 Downgrade
Raymond James
Strong Buy → Mkt Perform
Sep-13-18 Upgrade
JP Morgan
Underweight → Neutral
Jan-04-18 Upgrade
BofA/Merrill
Neutral → Buy
Dec-12-17 Upgrade
Robert W. Baird
Neutral → Outperform
$63 → $82
Dec-11-17 Upgrade
Citigroup
Neutral → Buy
Dec-07-17 Upgrade
Raymond James
Outperform → Strong Buy
Nov-08-17 Reiterated
RBC Capital Mkts
Sector Perform
$64 → $60
Oct-09-17 Downgrade
JP Morgan
Neutral → Underweight
Jun-26-17 Downgrade
Jefferies
Buy → Hold
Jan-20-21 07:47AM
Jan-05-21 12:18PM
09:59AM
06:00AM
Jan-04-21 09:26AM
Dec-31-20 11:50AM
Dec-29-20 11:40AM
10:15AM
Dec-28-20 12:18PM
Dec-25-20 07:50AM
Dec-23-20 01:45PM
10:21AM
Dec-22-20 10:38AM
06:07AM
Dec-21-20 08:35PM
11:38AM
Dec-17-20 12:56PM
Dec-15-20 11:50AM
Dec-14-20 12:46PM
Dec-11-20 12:55PM
Dec-10-20 11:40AM
Dec-07-20 01:16AM
Nov-27-20 11:50AM
10:54AM
08:30AM
Nov-25-20 06:46AM
Nov-24-20 11:40AM
Nov-23-20 06:04AM
Nov-20-20 09:02AM
Nov-19-20 07:54AM
Nov-17-20 08:48AM
Nov-16-20 11:30AM
Nov-11-20 11:50AM
Nov-10-20 10:24AM
Nov-06-20 11:40AM
Nov-05-20 11:00AM
09:53AM
Nov-04-20 12:21PM
02:13AM
Nov-03-20 01:53PM Investor's Business Daily
10:42AM
10:03AM
07:14AM
Nov-02-20 08:07AM
07:42AM
Nov-01-20 09:29AM
Oct-30-20 03:01PM
07:07AM
Oct-29-20 05:35PM
04:01PM
Oct-28-20 12:26PM
10:04AM
Oct-26-20 11:50AM
09:45AM
08:49AM
Oct-22-20 12:34PM
11:30AM
09:01AM
Oct-21-20 11:40AM
Oct-20-20 08:01AM
07:40AM
07:28AM
06:50AM
Oct-19-20 08:49AM
07:46AM
Oct-15-20 04:52PM
01:05PM
12:10PM
10:15AM
09:14AM
Oct-14-20 09:23AM
06:15AM
Oct-13-20 08:37AM
Oct-09-20 11:50AM
Oct-08-20 11:30AM
Oct-07-20 07:56AM
Oct-05-20 11:40AM
Oct-01-20 09:58AM
08:46AM
Sep-27-20 09:44AM
07:00AM
Sep-26-20 10:30AM
Sep-25-20 01:52PM
07:30AM
Sep-24-20 08:48AM
Sep-23-20 11:50AM
06:41AM
Sep-22-20 01:16PM
12:17PM
Sep-21-20 01:33PM
11:03AM
Sep-18-20 11:40AM
Sep-17-20 09:15AM
06:00AM
Sep-16-20 06:27PM
Sep-15-20 06:30AM
Sep-10-20 10:11AM
Sep-09-20 08:33AM
Sep-08-20 02:04PM
06:00AM
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2019, it provided dialysis and administrative services in the United States through a network of 2,753 outpatient dialysis centers serving approximately 206,900 patients; and operated 259 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 28,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DIAZ PAUL J Director Nov 30 Option Exercise 68.70 19,358 1,329,923 18,877 Dec 02 06:31 PM STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC Nov 30 Sale 109.74 25,000 2,743,515 42,431 Dec 02 06:31 PM Arway Pamela M Director Nov 20 Sale 107.88 430 46,388 19,239 Nov 23 07:22 PM STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC Nov 18 Option Exercise 69.92 67,100 4,691,908 132,576 Nov 19 07:24 PM STAFFIERI MICHAEL DAVID Chief Operating Officer, DKC Nov 17 Option Exercise 75.42 36,477 2,751,095 121,703 Nov 19 07:24 PM DESOER BARBARA J Director Nov 17 Sale 111.00 1,388 154,068 430 Nov 17 09:17 PM Arway Pamela M Director Nov 16 Option Exercise 68.70 19,358 1,329,923 31,292 Nov 17 09:15 PM Arway Pamela M Director Nov 16 Sale 111.63 7,326 817,801 19,669 Nov 17 09:15 PM DESOER BARBARA J Director Nov 11 Option Exercise 68.17 3,816 260,153 3,816 Nov 13 06:29 PM Waters Kathleen Alyce Chief Legal Officer Nov 10 Sale 105.01 10,000 1,050,129 55,874 Nov 12 06:17 PM NEHRA JOHN M Director Sep 23 Buy 82.95 2,500 207,374 5,500 Sep 24 06:22 PM NEHRA JOHN M Director Sep 22 Buy 84.60 3,000 253,814 3,000 Sep 24 06:22 PM ZUMWALT LEANNE M Group VP, Government Affairs Sep 18 Option Exercise 72.60 36,923 2,680,721 51,049 Sep 22 07:59 PM ZUMWALT LEANNE M Group VP, Government Affairs Sep 18 Sale 88.03 3,772 332,031 24,590 Sep 22 07:59 PM WESCHLER, R. TED Member of 10% owner group Sep 17 Sale 88.00 2,000,000 176,000,000 36,095,570 Sep 21 04:38 PM WESCHLER, R. TED Member of 10% owner group Sep 17 Sale 88.00 200,000 17,600,000 1,991,806 Sep 21 04:38 PM Arway Pamela M Director Aug 24 Sale 87.02 578 50,298 19,239 Aug 25 05:56 PM BERG CHARLES Director Jun 08 Option Exercise 81.51 4,662 380,000 15,666 Jun 10 06:21 PM DIAZ PAUL J Director Jun 08 Option Exercise 81.51 4,662 380,000 10,598 Jun 10 06:22 PM ROPER WILLIAM L Director Jun 08 Option Exercise 81.51 4,662 380,000 20,623 Jun 10 06:21 PM Arway Pamela M Director Jun 08 Option Exercise 81.51 4,662 380,000 23,901 Jun 10 06:21 PM NEHRA JOHN M Director Jun 08 Option Exercise 81.51 4,662 380,000 4,662 Jun 10 06:22 PM GRAUER PETER T Director Jun 08 Option Exercise 71.19 35,083 2,497,468 83,790 Jun 10 06:23 PM Arway Pamela M Director Jun 08 Sale 87.32 357 31,174 19,239 Jun 10 06:21 PM ROPER WILLIAM L Director Jun 08 Sale 86.79 357 30,983 15,961 Jun 10 06:21 PM BERG CHARLES Director Jun 08 Sale 87.53 357 31,249 11,004 Jun 10 06:21 PM Arway Pamela M Director May 22 Sale 78.90 599 47,261 19,239 May 27 04:05 PM DIAZ PAUL J Director May 18 Sale 82.22 5,763 473,825 9,986 May 19 09:19 PM THIRY KENT J Executive Chairman May 12 Sale 80.89 62,000 5,015,000 548,653 May 13 08:47 PM THIRY KENT J Executive Chairman May 11 Option Exercise 75.42 145,522 10,975,269 283,369 May 13 08:47 PM THIRY KENT J Executive Chairman May 11 Sale 81.28 62,000 5,039,391 610,653 May 13 08:47 PM THIRY KENT J Executive Chairman May 11 Sale 81.18 5,390 437,537 137,847 May 13 08:47 PM Arway Pamela M Director Mar 20 Sale 71.25 625 44,531 19,239 Mar 24 06:42 PM NEHRA JOHN M Director Mar 02 Sale 80.74 7,694 621,214 54,759 Mar 04 07:11 PM NEHRA JOHN M Director Feb 27 Sale 80.49 11,806 950,265 62,453 Feb 28 07:07 PM NEHRA JOHN M Director Feb 26 Sale 80.93 20,000 1,618,600 74,259 Feb 28 07:07 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite